Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a funding note for 2017 (NIH grant/contract) in the study identifiers and updated the page revision from v3.6.5 to v3.6.6, reflecting new funding information and the current document version.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page shows Revision: v3.6.5 replacing Revision: v3.6.4, indicating a small site revision. The update does not alter the study information or how users interact with the page.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous revision number. This indicates an updated version of the page, likely due to minor editorial or QC updates.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision tag has been updated to v3.6.3, indicating a newer build of the ClinicalTrials.gov entry. This generally reflects maintenance or bug fixes and does not alter trial data or study details.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a minor backend update. No study content or visible features were changed.SummaryDifference0.1%

- Check97 days agoChange DetectedNew navigation/help sections were added to assist users: 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The treatment section label was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated to v3.6.0 (replacing 3.5.5).SummaryDifference0.4%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.